| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9959885 | Journal of the American College of Cardiology | 2005 | 7 Pages |
Abstract
At five years of follow-up, in the ERACI II study, there were no survival benefits from any revascularization procedure; however patients initially treated with CABG had better freedom from repeat revascularization procedures and from MACE.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alfredo E. MD, PhD, FACC, Julio MD, PhD, Carlos Fernández MD, Jose MD, Máximo Rodriguez MD, Alejandro MD, Federico MD, Daniel MD, William MD, FACC, Igor F. MD, FACC,, the ERACI II Investigators the ERACI II Investigators,